All roads lead to COPD… or not?
octubre 11, 2023
Our understanding of the pathogenesis of COPD has changed very significantly over the past few years.
Our understanding of the pathogenesis of COPD has changed very significantly over the past few years.
The results of this post hoc analysis support the hypothesis that benralizumab reduces the risk for recurrent COPD exacerbations within the vulnerable 30-to-90–day period in the previously identified responder population.
Mediante esta noticia ponemos a vuestra disposición los documentos de las presentaciones de Alvar Agustí durante la sesión del Webinar «JOINT WEBINAR ON COPD 2023 GUIDELINES»
The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary